Clinical trial NCT02813811 - References

Asthma — Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.

Citation(s)

•   Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O'Byrne P, Partridge MR, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, Zuberbier T
  Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010 Nov;126(5):926-38. doi: 10.1016/j.jaci.2010.07.019.
•   Boyle RJ, Pedroletti C, Wickman M, Bjermer L, Valovirta E, Dahl R, Von Berg A, Zetterström O, Warner JO; 4A Study Group
  Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial. Thorax. 2012 Mar;67(3):215-21. doi: 10.1136/thoraxjnl-2011-200665. Epub 2011 Nov 30.
•   Brodtkorb TH, Zetterström O, Tinghög G
  Cost-effectiveness of clean air administered to the breathing zone in allergic asthma. Clin Respir J. 2010 Apr;4(2):104-10. doi: 10.1111/j.1752-699X.2009.00156.x.
•   Campbell MJ, Holgate ST, Johnston SL
  Trends in asthma mortality. Data on seasonality of deaths due to asthma were omitted from paper but editorial's author did not know. BMJ. 1997 Oct 18;315(7114):1012.
•   Custovic A, Simpson A, Chapman MD, Woodcock A
  Allergen avoidance in the treatment of asthma and atopic disorders. Thorax. 1998 Jan;53(1):63-72. Review.
•   Custovic A, Taggart SC, Francis HC, Chapman MD, Woodcock A
  Exposure to house dust mite allergens and the clinical activity of asthma. J Allergy Clin Immunol. 1996 Jul;98(1):64-72.
•   Gøtzsche PC, Johansen HK
  House dust mite control measures for asthma: systematic review. Allergy. 2008 Jun;63(6):646-59. doi: 10.1111/j.1398-9995.2008.01690.x. Review.
•   Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A
  Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002 Mar 30;324(7340):763. Erratum in: BMJ 2002 May 11;324(7346):1131.
•   Grootendorst DC, Dahlén SE, Van Den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJ, O'Sullivan S, Kumlin M, Sterk PJ, Roldaan AC
  Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy. 2001 Mar;31(3):400-8.
•   Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM; British Thoracic Society Difficult Asthma Network
  Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax. 2010 Sep;65(9):787-94. doi: 10.1136/thx.2010.137414.
•   Holgate ST, Polosa R
  The mechanisms, diagnosis, and management of severe asthma in adults. Lancet. 2006 Aug 26;368(9537):780-93. Review.
•   Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP
  Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009 Oct;34(5):447-54. doi: 10.1111/j.1749-4486.2009.01995.x.
•   Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S
  Risk factors and costs associated with an asthma attack. Thorax. 2000 Jan;55(1):19-24.
•   Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K
  Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005 Mar;60(3):309-16.
•   Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR
  Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999 Jul;14(1):32-8.
•   Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR
  Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999 Oct;14(4):902-7.
•   Juniper EF, Svensson K, Mörk AC, Ståhl E
  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005 May;99(5):553-8. Epub 2004 Nov 26.
•   Langley SJ, Goldthorpe S, Craven M, Morris J, Woodcock A, Custovic A
  Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol. 2003 Aug;112(2):362-8.
•   Manson SC, Brown RE, Cerulli A, Vidaurre CF
  The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med. 2009 Jul;103(7):975-94. doi: 10.1016/j.rmed.2009.01.003. Epub 2009 Apr 15. Review.
•   Nejtek VA, Brown ES, Khan DA, Moore JJ, Van Wagner J, Perantie DC
  Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann Allergy Asthma Immunol. 2001 Aug;87(2):129-33.
•   Peroni DG, Boner AL, Vallone G, Antolini I, Warner JO
  Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1994 Jun;149(6):1442-6.
•   Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA
  Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008 Apr;102(4):519-36. doi: 10.1016/j.rmed.2007.11.016. Epub 2008 Jan 3.
•   Reilly MC, Zbrozek AS, Dukes EM
  The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993 Nov;4(5):353-65.
•   Rodrigo GJ, Rodrigo C, Hall JB
  Acute asthma in adults: a review. Chest. 2004 Mar;125(3):1081-102. Review.
•   Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, Malveaux F
  The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997 May 8;336(19):1356-63.
•   Schauer U, Bergmann KC, Gerstlauer M, Lehmann S, Gappa M, Brenneken A, Schulz C, Ahrens P, Schreiber J, Wittmann M, Hamelmann E; all members of the German Asthma Net (GAN)
  Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisons. Eur Clin Respir J. 2015 Jul 29;2. doi: 10.3402/ecrj.v2.28531. eCollection 2015.
•   Sublett JL
  Effectiveness of air filters and air cleaners in allergic respiratory diseases: a review of the recent literature. Curr Allergy Asthma Rep. 2011 Oct;11(5):395-402. doi: 10.1007/s11882-011-0208-5. Review.
•   Tough SC, Hessel PA, Ruff M, Green FH, Mitchell I, Butt JC
  Features that distinguish those who die from asthma from community controls with asthma. J Asthma. 1998;35(8):657-65.
•   Tunnicliffe WS, Fletcher TJ, Hammond K, Roberts K, Custovic A, Simpson A, Woodcock A, Ayres JG
  Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J. 1999 Mar;13(3):654-9.
•   Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM
  Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1804-9.
•   van Velzen E, van den Bos JW, Benckhuijsen JA, van Essel T, de Bruijn R, Aalbers R
  Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax. 1996 Jun;51(6):582-4.

A Prospective, Single Arm, Cohort Study of Nocturnal Temperature-controlled Laminar Airflow (TLA) Treatment (Airsonett®) in Patients With Allergic Asthma to Determine the Effect of Long-term Treatment on Exacerbation Frequency.

Details for clinical trial NCT02813811